Published online before print August 7, 2008

This Article Full Text Full Text (PDF) Supplemental Material All Versions of this Article: ajpath.2008.080096v1 173/3/856    most recent Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Connolly, E. Articles by Rogler, C. E. Search for Related Content PubMed PubMed Citation Articles by Connolly, E. Articles by Rogler, C. E.

(American Journal of Pathology. 2008;173:856-864.)
© 2008 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2008.080096

Elevated Expression of the miR-17–92 Polycistron and miR-21 in Hepadnavirus-Associated Hepatocellular Carcinoma Contributes to the Malignant Phenotype

Erin Connolly^*, Margherita Melegari^*, Pablo Landgraf, Tatyana Tchaikovskaya^*, Bud C. Tennant, Betty L. Slagle, Leslie E. Rogler^*, Mihaela Zavolan^¶, Thomas Tuschl and Charles E. Rogler^*

From the Marion Bessin Liver Research Center,^* Department of Medicine, Albert Einstein College of Medicine, Bronx, NY; Laboratory of RNA Biology, Rockefeller University, New York, NY; Department of Animal Science, Cornell University College of Veterinary Medicine, Ithaca, NY; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas;^¶ Biozentrum, University of Basel, Switzerland and Swiss Institute of Bioinformatics, Lausanne, Switzerland

Alterations in microRNA (miRNA) expression in both human and animal models have been linked to many forms of cancer. Such miRNAs, which act directly as repressors of gene expression, have been found to frequently reside in fragile sites and genomic regions associated with cancer. This study describes a miRNA signature for human primary hepatitis B virus-positive human hepatocellular carcinoma. Moreover, two known oncomiRs—miRNAs with known roles in cancer—the miR-17–92 polycistron and miR-21, exhibited increased expression in 100% of primary human and woodchuck hepatocellular carcinomas surveyed. To determine the importance of these miRNAs in tumorigenesis, an in vitro antisense oligonucleotide knockdown model was evaluated for its ability to reverse the malignant phenotype. Both in human and woodchuck HCC cell lines, separate treatments with antisense oligonucleotides specific for either the miR-17–92 polycistron (all six members) or miR-21 caused a 50% reduction in both hepatocyte proliferation and anchorage-independent growth. The combination of assays presented here supports a role for these miRNAs in the maintenance of the malignant transformation of hepatocytes.

This article has been cited by other articles:

				Q. Pan, X. Luo, and N. Chegini microRNA 21: response to hormonal therapies and regulatory function in leiomyoma, transformed leiomyoma and leiomyosarcoma cells Mol. Hum. Reprod., March 1, 2010; 16(3): 215 - 227. [Abstract] [Full Text] [PDF]

				M. Raponi, L. Dossey, T. Jatkoe, X. Wu, G. Chen, H. Fan, and D. G. Beer MicroRNA Classifiers for Predicting Prognosis of Squamous Cell Lung Cancer Cancer Res., July 15, 2009; 69(14): 5776 - 5783. [Abstract] [Full Text] [PDF]